Takeda - Better Health, Brighter Future

Better Health, Brighter Future

FY2019 Q4 Financial Results Highlights

LEARN MORE

Welcome to the global
corporate site for Takeda.

If you are looking for specific information,
please visit our country/region website.

SELECT A COUNTRY OR REGION SITE

Guided by Our Values: Supporting Global COVID-19 Response

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

RECENT NEWS STOCK PRICE

May 29, 2020 May 29, 2020

Takeda to Present Data from the ICLUSIG^® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML

Please wait...

Topics

World IBD Day - 19 May 2020

Approach to the Environment

Our Coronavirus Efforts and How You Can Help

Quarterly Announcements FY 2019 Q4 Results

Information

144th Ordinary General Meeting of Shareholders (11:00am JST on June 24th, 2020)

Oncology Focused Investor Call (June 8th at 8:00am EDT / 9:00pm JST)

FY2019 Q4 Financial Results Announcement (3:00pm JST on May 13th, 2020)
Q4 Results Conference Call (presentation & Q&A) For Media: 4:45pm-5:30pm JST
Q4 Results Conference Call (presentation & Q&A) For Investors & Analysts: 6:00pm-7:15pm JST
Alternative Timezone Conference Call (Q&A only): 9:30pm-10:30pm JST

Information for US patients regarding the NATPARA recall in the US.
NATPARA is still available in markets outside of the US.

Offer for Shire plc

Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.